Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,173 | 98,012 | 168,740 | 164,397 | 114,745 |
| Marketable Securities | 343,721 | 335,682 | 300,474 | 152,525 | 182,788 |
| Receivables | 33,582 | 26,574 | 22,133 | 14,695 | 14,473 |
| Inventories | 8,404 | 4,393 | 5,146 | 9,331 | 15,172 |
| TOTAL | $462,032 | $484,470 | $510,372 | $353,345 | $340,834 |
| Non-Current Assets | |||||
| PPE Net | 4,789 | 4,937 | 3,520 | 3,232 | 3,330 |
| Other Non-Current Assets | 7,933 | 6,062 | 6,053 | 572 | 622 |
| TOTAL | $12,722 | $10,999 | $9,573 | $3,804 | $3,952 |
| Total Assets | $474,754 | $495,469 | $519,945 | $357,149 | $344,786 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 86,965 | 82,460 | 77,211 | 61,433 | 45,515 |
| Accounts payable and accrued liabilities | 6,187 | 3,628 | 7,948 | 4,152 | 5,650 |
| Accrued Expenses | 35,030 | 31,889 | 39,601 | 32,370 | 26,934 |
| TOTAL | $132,429 | $119,224 | $131,328 | $102,048 | $82,615 |
| Non-Current Liabilities | |||||
| Long Term Debt | 79,080 | 102,696 | 125,140 | 145,417 | 165,517 |
| Deferred Revenues | 4,247 | 1,247 | 6,568 | 4,093 | 4,516 |
| Other Non-Current Liabilities | 2,314 | 2,479 | 814 | 540 | 710 |
| TOTAL | $87,400 | $111,181 | $180,251 | $182,712 | $204,006 |
| Total Liabilities | $219,829 | $230,405 | $311,579 | $284,760 | $286,621 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 144,304 | 143,966 | 143,077 | 142,357 | 141,915 |
| Common Shares | 144 | 144 | 143 | 142 | 142 |
| Retained earnings | -501,461 | -478,569 | -522,371 | -646,253 | -649,002 |
| Other shareholders' equity | -736 | -870 | -450 | -53 | -61 |
| TOTAL | $254,925 | $265,064 | $208,366 | $72,389 | $58,165 |
| Total Liabilities And Equity | $474,754 | $495,469 | $519,945 | $357,149 | $344,786 |